13F 机构持仓

Rock Springs Capital Management LP

Baltimore MD · SEC CIK 0001595725

2026Q22026Q1 更早 9 个季度 🔒
$20.49亿2026Q2 申报市值
104持仓数
44.0%前十大占比 · 第一大 10.1%
17 / 13新建仓 / 清仓
申报市值走势$20.49亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

RVMD 10.1%
TVTX 6.0%
LLY 5.8%
MDGL 4.6%
MIRM 4.6%
RYTM 3.8%
KYMR 2.5%
ARGX 2.4%
ASND 2.2%
XENE 2.0%

2026Q2 买入最多 按季末市值估算

ASND 新建仓+$4,500.90万
TVTX 加仓+$3,983.03万
AVLN 新建仓+$2,182.33万
COAG 新建仓+$2,113.56万
PBLS 新建仓+$1,582.06万

2026Q2 卖出最多 按季末市值估算

ASND 清仓-$4,437.36万
ARGX 减仓-$4,244.55万
RVMD 减仓-$1,952.49万
ARCELLX INC 清仓-$1,950.32万
ELVN 减仓-$1,836.52万

2026Q2 持仓明细 点表头排序 · 每页 100 行

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
ISRG INTUITIVE SURGICAL INC $3,040.66万1.48%76,460 -5,540-6.8% -$220.31万 减仓
IRTC IRHYTHM HOLDINGS INC $3,207.49万1.57%269,650 7,9003.0% $93.97万 加仓
RARE ULTRAGENYX PHARMACEUTICAL IN $3,231.67万1.58%967,855 -250,918-20.6% -$837.82万 减仓
GPCR STRUCTURE THERAPEUTICS INC $3,436.58万1.68%640,317 1000.0% $5,367 加仓
PEN PENUMBRA INC $3,654.81万1.78%115,750 -4,750-3.9% -$149.98万 减仓
INSM INSMED INC $3,861.24万1.88%362,150 47,85015.2% $510.18万 加仓
SRRK SCHOLAR ROCK HLDG CORP $3,934.99万1.92%715,452 -24,364-3.3% -$134.00万 减仓
XENE XENON PHARMACEUTICALS INC $4,128.06万2.01%683,907 -79,113-10.4% -$477.53万 减仓
ASND ASCENDIS PHARMA A/S $4,500.90万2.20%168,750 168,750— $4,500.90万 新建仓
ARGX ARGENX SE $4,893.99万2.39%52,750 -45,750-46.4% -$4,244.55万 减仓
KYMR KYMERA THERAPEUTICS INC $5,196.34万2.54%453,156 -43,715-8.8% -$501.28万 减仓
RYTM RHYTHM PHARMACEUTICALS INC $7,689.92万3.75%692,598 2,8500.4% $31.64万 加仓
MIRM MIRUM PHARMACEUTICALS INC $9,343.88万4.56%798,145 -13,149-1.6% -$153.94万 减仓
MDGL MADRIGAL PHARMACEUTICALS INC $9,396.57万4.59%174,999 4,0002.3% $214.78万 加仓
LLY ELI LILLY & CO $1.18亿5.78%98,700 00.0% — 不变
TVTX TRAVERE THERAPEUTICS INC $1.24亿6.04%2,179,069 701,11547.4% $3,983.03万 加仓
RVMD REVOLUTION MEDICINES INC $2.07亿10.10%1,105,210 -104,255-8.6% -$1,952.49万 减仓